Genetic Insurance Discrimination in Sudden Arrhythmia Death Syndromes

نویسندگان

  • Saira Mohammed
  • Zaneta Lim
  • H. Dean
  • James E. Potts
  • N. C. Tang
  • Susan P. Etheridge
  • Pam Husband
  • Elizabeth D. Sherwin
  • Michael J. Ackerman
  • Shubhayan Sanatani
چکیده

Sudden unexpected death is defined as a natural unexpected fatal event that occurs within 1 hour of the onset of symptoms in an apparently healthy subject or in one whose disease was not so severe as to predict such an abrupt outcome. Approximately 294 851 adults and 2000 children die of sudden unexpected death in the United States each year. Evidence from a Danish population suggests an incidence of sudden cardiac death in those aged 1 to 35 of 2.8 per 100 000 person-years; this estimate accounts for roughly 7% of all deaths in people aged 1 to 35 years. A large proportion of cases in the young are because of arrhythmias secondary to inherited cardiac diseases, primarily cardiomyopathies and channelopathies often referred to as Sudden Arrhythmia Death Syndromes (SADS). SADS may account for 17% to 43% of all sudden cardiac death cases in the young. Primary electric diseases or channelopathies include Brugada Syndrome, catecholaminergic polymorphic ventricular tachycardia, Long QT interval is a measurement of time between the start of the Q wave and the end of the T wave syndrome which occur because of genetic alterations in the ion channels controlling the electric activity of the heart. Cardiomyopathies include hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy in which arrhythmias are associated with structural changes in the heart.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic Insurance Discrimination in Sudden Arrhythmia Death Syndromes: Empirical Evidence From a Cross-Sectional Survey in North America.

BACKGROUND There is virtually no information assessing the insurability of families affected with Sudden Arrhythmia Death Syndromes (SADS) for the determination of the nonclinical implications of genetic screening. It is important to identify the barriers and challenges faced by families as a result of genetic screening for SADS to enable equitable access to insurance coverage. METHODS AND RE...

متن کامل

Electrophysiological interventions for inherited arrhythmia syndromes.

IInherited arrhythmia syndromes are electrical myopathies with genetic origins and risk of sudden death. They may present from infancy through adulthood, although the specific diseases have stereotypic but variable phenotypic onset and severity. There is clinical and genetic overlap among the syndromes, with variable penetrance and expressivity. Although underlying mechanisms of arrhythmogenesi...

متن کامل

Cardiac Arrhythmia 3 Ventricular arrhythmias and sudden cardiac death

Management strategies for ventricular arrhythmias are guided by the risk of sudden death and severity of symptoms. Patients with a substantial risk of sudden death usually need an implantable cardioverter defibrillator (ICD). Although ICDs effectively end most episodes of ventricular tachycardia or ventricular fibrillation and decrease mortality in specific populations of patients, they have in...

متن کامل

TECRL: connecting sequence to consequence for a new sudden cardiac death gene

The sudden unexpected death of a child is a devastating event. One of the first questions a family will ask is “Why did this happen?” In some cases, the answer may become obvious during a postmortem examination, but in up to 40% of cases, the postmortem is negative (Bagnall et al, 2016). In the last 1–2 decades, an improved understanding of the genetic basis of the primary arrhythmia syndromes,...

متن کامل

A Case Report of Familial Sudden Cardiac Death

The annual incidence of sudden cardiac death (SCD) in the general population is 0.1%. SCDs in the young are mainly caused by genetic heart disorders which can lead to inherited arrhythmia syndromes, such as long QT, short QT and Brugada syndromes. One of the most effective therapies for this disease is implantable cardioverter defibrillators (ICD). In this article, we reported a case of 46 year...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2017